Jim Simons Matinas Bio Pharma Holdings, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.15 - $0.37 $4,965 - $12,247	33,100 Added 7.99%	447,137 $71,000
Q1 2024 May 13, 2024	BUY	$0.19 - $0.3 $8,056 - $12,720	42,400 Added 11.41%	414,037 $112,000
Q4 2023 Feb 13, 2024	BUY	$0.12 - $0.64 $18,876 - $100,672	157,300 Added 73.39%	371,637 $80,000
Q3 2023 Nov 14, 2023	BUY	$0.12 - $0.41 $8,188 - $27,977	68,237 Added 46.71%	214,337 $28,000
Q2 2023 Aug 11, 2023	SELL	$0.35 - $0.72 $9,040 - $18,596	-25,829 Reduced 15.02%	146,100 $53,000
Q1 2023 May 12, 2023	BUY	$0.39 - $0.6 $19,824 - $30,499	50,833 Added 41.98%	171,929 $81,000
Q4 2022 Feb 13, 2023	BUY	$0.46 - $42.69 $40,156 - $3.73 Million	87,296 Added 258.27%	121,096 $61,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $33.0 $21,294 - $1.12 Million	33,800 New	33,800 $21,000
Q3 2021 Nov 12, 2021	SELL	$0.67 - $1.51 $408,131 - $919,819	-609,152 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$0.75 - $1.1 $351,561 - $515,623	468,749 Added 333.86%	609,152 $472,000
Q1 2021 May 13, 2021	SELL	$0.96 - $1.74 $1.04 Million - $1.88 Million	-1,078,759 Reduced 88.48%	140,403 $147,000
Q4 2020 Feb 10, 2021	BUY	$0.76 - $1.47 $926,563 - $1.79 Million	1,219,162 New	1,219,162 $1.66 Million
Q3 2020 Nov 13, 2020	SELL	$0.67 - $0.96 $178,890 - $256,320	-267,000 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$0.52 - $0.92 $393,796 - $696,716	-757,300 Reduced 73.93%	267,000 $206,000
Q1 2020 May 14, 2020	BUY	$0.6 - $2.31 $435,814 - $1.68 Million	726,358 Added 243.79%	1,024,300 $615,000
Q4 2019 Feb 13, 2020	BUY	$0.63 - $2.27 $187,703 - $676,328	297,942 New	297,942 $676,000
Q2 2019 Aug 12, 2019	SELL	$0.79 - $1.11 $199,870 - $280,830	-253,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$0.6 - $1.41 $151,800 - $356,730	253,000 New	253,000 $276,000

Others Institutions Holding MTNB

# of Institutions

Shares Held

3.52M

Call Options Held

Put Options Held

View Full List

About Matinas BioPharma Holdings, Inc.

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

More about MTNB

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account